Histopathology and molecular genetics of renal tumors toward unification of a classification system.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Urology

• Publication date

  1999-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0022-5347(05)68259-6PMID 10492174
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metanephric adenoma.

  2020cited by this paper
• Genetic changes in the origin and development of renal cell carcinoma (RCC)

  2006cited by this paper
• Preoperative diagnosis of renal oncocytoma and treatment possibilities

  2005cited by this paper
• The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours

  2004cited by this paper
• Novel mutations of the MET proto-oncogene in papillary renal carcinomas

  1999cited by this paper
• Chromophobe Cell Renal Carcinoma

  1999cited by this paper
• Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases.

  1999cited by this paper
• Papillary and metanephric adenomas of the kidney.

  1998cited by this paper
• Chromophobe renal cell carcinoma: clinicopathological study of 7 cases.

  1998cited by this paper
• Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining.

  1998cited by this paper
• A familial case of renal cell carcinoma and a t(2;3) chromosome translocation.

  1998cited by this paper
• Translocation (X;1)(p11.2;q21) in a papillary renal cell carcinoma in a 14-year-old girl.

  1998cited by this paper
• Collecting duct carcinomas of the kidney: a comparative loss of heterozygosity study with clear cell renal cell carcinoma.

  1998cited by this paper
• An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation.

  1998cited by this paper
• Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene.

  1998cited by this paper
• Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas

  1998cited by this paper
• Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor.

  1998cited by this paper
• Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas

  1998cited by this paper
• Familial renal oncocytoma: clinicopathological study of 5 families.

  1998cited by this paper
• Transforming Growth Factor α Is a Target for the Von Hippel-Lindau Tumor Suppressor

  1998cited by this paper
• Mutational state of von Hippel-Lindau and adenomatous polyposis coli genes in renal tumors.

  1997cited by this paper
• Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.

  1997cited by this paper
• Classification of renal cell carcinoma

  1997cited by this paper
• Immunodetection of c-met-oncogene's protein product in renal cell neoplasia.

  1997cited by this paper
• Involvement of the chromosomal region 11q13 in renal oncocytoma: case report and literature review.

  1997cited by this paper
• Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features.

  1997cited by this paper
• Activating mutations for the met tyrosine kinase receptor in human cancer.

  1997cited by this paper
• C-met proto-oncogene expression in benign and malignant human renal tissues.

  1997cited by this paper
• Renal medullary carcinoma and sickle cell trait.

  1997cited by this paper
• Duplication of an approximately 1.5 Mb DNA segment at chromosome 5q22 indicates the locus of a new tumour gene in nonpapillary renal cell carcinomas

  1997cited by this paper
• FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas

  1997cited by this paper
• Retrospective evaluation of c-erbB-2 oncogene amplification using competitive PCR in collecting duct carcinoma of the kidney.

  1997cited by this paper
• Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.

  1997cited by this paper
• Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

  1997cited by this paper
• Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non‐papillary renal cell carcinomas

  1997cited by this paper
• Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.

  1997cited by this paper
• Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas.

  1997cited by this paper
• Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.

  1997cited by this paper
• Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour

  1997cited by this paper
• Renal oncocytoma: a clinicopathologic study of 70 cases.

  1997cited by this paper
• Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas.

  1997cited by this paper
• Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: an ultrastructural study of 60 tumors.

  1997cited by this paper
• Cytologic and fluorescence in situ hybridization (FISH) examination of metanephric adenoma

  1997cited by this paper
• Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

  1997cited by this paper
• Renal medullary carcinoma: a recently described highly aggressive renal tumor in young black patients.

  1997cited by this paper
• Fine‐needle aspiration of metastatic clear cell carcinoma of the kidney

  1997cited by this paper
• Fine mapping of the human renal oncocytoma-associated translocation (5;11)(q35;q13) breakpoint.

  1997cited by this paper
• Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival.

  1997cited by this paper
• Genetics as a diagnostic tool in sarcomatoid renal‐cell cancer

  1997cited by this paper
• The Heidelberg classification of renal cell tumours

  1997cited by this paper
• Re: Hereditary Papillary Renal Cell Carcinoma; Re Hereditary Papillary Renal Cell Carcinoma Clinical Studies in 10 Families

  1996cited by this paper
• Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor suppressor gene for renal oncocytomas

  1996cited by this paper
• [Histogenesis of renal cell carcinoma].

  1996cited by this paper
• The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma.

  1996cited by this paper
• The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

  1996cited by this paper
• The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene.

  1996cited by this paper
• Distal nephron renal tumors: microsatellite allelotype.

  1996cited by this paper
• Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study.

  1996cited by this paper
• Mapping of 29 YAC clones and identification of 3 YACs spanning the translocation t(3;8)(p14.2;q24.1) breakpoint at 8q24.1 in hereditary renal cell carcinoma.

  1996cited by this paper
• Papillary Renal Cell Carcinoma: Quantitation of Chromosomes 7 and 17 by FISH, Analysis of Chromosome 3p for LOH, and DNA Ploidy

  1996cited by this paper
• Cytogenetic findings in renal cell carcinoma.

  1996cited by this paper
• High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1-32.2.

  1996cited by this paper
• Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis.

  1996cited by this paper
• Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma.

  1996cited by this paper
• Cytogenetic analysis of three primary Bellini duct carcinomas

  1996cited by this paper
• Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas.

  1996cited by this paper
• The t(1; 12)(p36;q13) in a Renal Oncocytoma

  1996cited by this paper
• Overexpression of the met/HGF receptor in renal cell carcinomas

  1996cited by this paper
• Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.

  1996cited by this paper
• MUTATION OF THE VHL GENE IS ASSOCIATED EXCLUSIVELY WITH THE DEVELOPMENT OF NON‐PAPILLARY RENAL CELL CARCINOMAS

  1996cited by this paper
• Renal medullary carcinoma: Clinical and therapeutic aspects of a newly described tumor

  1996cited by this paper
• Frequent expression of Bcl‐2 in renal‐cell carcinomas carrying wild‐type p53

  1996cited by this paper
• The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma

  1996cited by this paper
• Metanephric adenoma: histology, immunophenotype, cytogenetics, ultrastructure.

  1996cited by this paper
• Metaphase analysis of metanephric adenoma reveals chromosome Y loss with chromosome 7 and 17 gain.

  1996cited by this paper
• Chromosomal findings and p53‐mutation analysis in chromophilic renal‐cell carcinomas

  1996cited by this paper
• Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation

  1996cited by this paper
• Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization.

  1996cited by this paper
• Concomitant overexpression of the EGFR and erbB‐2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis

  1996cited by this paper
• Comprehensive Textbook of Genitourinary Oncology

  1996cited by this paper
• Bellini duct carcinoma. A clinical and in vitro study.

  1996cited by this paper
• A singular case of near-haploid stemline karyotype in a renal oncocytoma.

  1996cited by this paper
• Cytogenetic analysis of three primary Bellini duct carcinomas.

  1996cited by this paper
• Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.

  1996cited by this paper
• Molecular cloning of the papillary renal cell carcinoma-associated translocation (X;1)(p11;q21) breakpoint.

  1996cited by this paper
• Renal cell carcinoma in an end-stage kidney of a patient with a functional transplant: cytogenetic and molecular genetic findings.

  1996cited by this paper
• Chromophobe Renal Cell Carcinoma

  1996cited by this paper
• Chromophobe cell carcinoma of the kidney. A clinicopathologic study of 21 cases.

  1995cited by this paper
• Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.

  1995cited by this paper
• Original Articles: Kidney Cancer

  1995cited by this paper
• Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation.

  1995cited by this paper
• Frequent Loss of Chromosome Arms 8p and 13q in Collecting Duct Carcinoma (CDC) of the Kidney

  1995cited by this paper
• Chromophobe cell renal carcinoma: clinicopathological features of 50 cases.

  1995cited by this paper
• Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.

  1995cited by this paper
• Absence of ras Mutations and Low Incidence of p53 Mutations in Renal Cell Carcinomas Induced by Ferric Nitrilotriacetate

  1995cited by this paper
• Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case.

  1995cited by this paper
• Cytogenetic characterization of a familial papillary renal cell carcinoma.

  1995cited by this paper
• Metanephric adenoma of the kidney: a clinicopathological, immunohistochemical, flow cytometric, cytogenetic, and electron microscopic study of seven cases

  1995cited by this paper
• c-met proto-oncogene expression in benign and malignant human prostate tissues.

  1995cited by this paper
• Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas.

  1995cited by this paper

• Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers.

  2023cites this paper
• MiR-24-1-5p Hinders Malignant Phenotypes of Clear Cell Renal Cell Carcinoma by Targeting SHOX2

  2023cites this paper
• Recent pharmacological approaches for the treatment of renal cell carcinoma

  2022cites this paper
• Long non‐coding RNA TMPO‐AS1 facilitates the progression of colorectal cancer cells via sponging miR‐98‐5p to upregulate BCAT1 expression

  2021cites this paper
• lncRNA RPL34‐AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR‐3663‐3p/RGS4 in papillary thyroid cancer

  2020cites this paper
• Sporadic Oncocytic Tumors with Features Intermediate between Oncocytoma and Chromophobe Renal Cell Carcinoma: Comprehensive Clinico-Pathological and Genomic Profiling

  2020cites this paper
• High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma.

  2019cites this paper
• Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma

  2019cites this paper
• AK001058 promotes the proliferation and migration of colorectal cancer cells by regulating methylation of ADAMTS12.

  2019cites this paper
• Benign and Malignant Diseases of the Prostate

  2019cites this paper
• The long noncoding RNA BC0209135 inhibits the cell invasion through Wnt/β-catenin signaling in colorectal cancer.

  2018cites this paper
• Predict MiRNA-Disease Association with Collaborative Filtering

  2018cites this paper
• Renal Mass Biopsy

  2018cites this paper
• A Phage Display-Identified Peptide Selectively Binds to Kidney Injury Molecule-1 (KIM-1) and Detects KIM-1–Overexpressing Tumors In Vivo

  2018cites this paper
• GIMDA: Graphlet interaction‐based MiRNA‐disease association prediction

  2017cites this paper
• Reciprocal control of lncRNA-BCAT1 and β-catenin pathway reveals lncRNA-BCAT1 long non-coding RNA acts as a tumor suppressor in colorectal cancer

  2017cites this paper
• Signalling and expression of the Ang-Tie pathway in tumor vasculature

  2016cites this paper
• HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction

  2016cites this paper
• Wnt Signaling in Renal Cell Carcinoma

  2016cites this paper
• Gr upSM Renal Cell Carcinoma : From a Pathologist ’ s Perspective

  2016cites this paper
• Ancillary Diagnostic Techniques in the Evaluation of Adult Epithelial Renal Neoplasms: Indications, Caveats, and Pitfalls

  2014cites this paper
• MicroRNAs in the Development and Progression of Kidney Cancer

  2014cites this paper
• Mixed collecting duct and renal cell carcinoma presenting with spinal cord compression

  2013cites this paper
• Incidental Detection of Renal Cell Carcinoma is an Independent Prognostic Marker of Survival

  2013cites this paper
• Rational therapy for renal cell carcinoma based on its genetic targets.

  2013cites this paper
• Molecular and Cellular Pathobiology Expression of the PTTG 1 Oncogene Is Associated with Aggressive Clear Cell Renal Cell Carcinoma

  2012cites this paper
• Association of RASSF1A genotype and haplotype with the progression of clear cell renal cell carcinoma in Japanese patients

  2012cites this paper
• Collecting duct carcinoma: a rare renal tumor.

  2012cites this paper
• Renal Mass Biopsy

  2012cites this paper
• Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists.

  2012cites this paper
• Malignant Renal Tumors

  2012cites this paper
• Shedding of kidney injury molecule-1 by membrane-type 1 matrix metalloproteinase.

  2012cites this paper
• Uncommon Tumors of the Kidney

  2012cites this paper
• Renal mass sampling: An enlightened perspective

  2011cites this paper
• The emerging role of nuclear factor kappa B in renal cell carcinoma.

  2011cites this paper
• Neoplasms of the Kidney and Bladder

  2011cites this paper
• Epigenetics of kidney cancer and bladder cancer.

  2011cites this paper
• Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death

  2011cites this paper
• The complex roles of Wnt antagonists in RCC

  2011cites this paper
• Extensive infiltrating renal cell carcinoma with minimal distortion of the renal anatomy mimicking benign renal vein thrombosis.

  2010cites this paper
• Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.

  2010cites this paper
• BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.

  2009cites this paper
• RENAL EPITHELIAL TUMORS 2009: THE ROLE OF ELECTRON MICROSCOPY IN UNDERSTANDING PATHOGENESIS, DIAGNOSIS, AND CLASSIFICATION.

  2009cites this paper
• An investigation into how the cell cycle and the Notch signalling pathway regulate pronephrogenesis in Xenopus laevis

  2009cites this paper
• Long term follow-up of Thalidomide plus Interleukin-2 based therapy in metastatic renal cell cancer patients Research

  2009cites this paper
• Renal cell carcinoma

  2009cites this paper
• Long term follow-up of Thalidomide plus interleukin-2 based therapy in metastatic renal cell cancer patients

  2009cites this paper
• Mitochondria and Oncocytomas

  2009cites this paper
• In vitro cytotoxic effects of Senecio stabianus Lacaita (Asteraceae) on human cancer cell lines

  2009cites this paper
• Hereditary kidney cancer

  2009cites this paper
• Mitochondria and cancer

  2009cites this paper
• The importance of benign kidney tumors among small renal masses: diagnosis and treatment algorithms

  2009cites this paper
• Contemporary Epidemiology of Renal Cell Cancer

  2008cites this paper
• Molecular characterisation of the peripheral Benzodiazepine receptor in various human cancer tissues

  2008cites this paper
• Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.

  2008cites this paper
• Treatment options for metastatic renal cell carcinoma: a review.

  2008cites this paper
• Interferon-&agr; in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial

  2008cites this paper
• Ce qu'il faut retenir

  2008cites this paper
• Origin of renal cell carcinomas

  2008cites this paper
• Molecular Biology of Kidney Cancer

  2008cites this paper
• Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells

  2008cites this paper
• EXPRESSIÓ DE KIT I PDGFR EN TUMORS DE CÈL·LULES RENALS "DISCUSSIÓ DEL SEU PAPER COM A POSSIBLES DIANES TERAPÈUTIQUES"

  2008cites this paper
• Phase II Study of Combination Thalidomide/Interleukin-2 Therapy Plus Granulocyte Macrophage-Colony Stimulating Factor in Patients With Metastatic Renal Cell Carcinoma

  2008cites this paper
• Epidemiology of Renal Tumors

  2008cites this paper
• Chemotherapy for Metastatic Clear-Cell Renal Cell Carcinoma

  2008cites this paper
• Gene therapy for renal cancer.

  2008cites this paper
• The expression of polyspecific transporters in renal tumors and their role in chemotherapeutical treatment

  2008cites this paper
• Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.

  2008cites this paper
• Origin of renal cell carcinomas.

  2008cites this paper
• Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma.

  2007cites this paper
• Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.

  2007cites this paper
• Valor pronóstico del tamaño nucleolar en el carcinoma de células renales - estudio mediante morfometría ultraestructural

  2007influential citation
• Gene methylation and early detection of genitourinary cancer: the road ahead

  2007cites this paper
• Aberrant methylation of the 8 p 22 tumor suppressor gene DLC 1 in renal cell carcinoma

  2007cites this paper
• Integrated therapy of kidney cancer.

  2007cites this paper
• Claudin-7 is Highly Expressed in Chromophobe Renal Cell Carcinoma and Renal Oncocytoma

  2007cites this paper
• Five‐year survival after surgical treatment for kidney cancer

  2007cites this paper
• Does PET imaging have a role in renal cancers after all?

  2007cites this paper
• Renal cell carcinoma

  2007cites this paper
• S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma

  2007cites this paper
• Jacaranone: A cytotoxic constituent fromsenecio ambiguus subsp.ambiguus (Biv.) DC. Against renal adenocarcinoma achn and prostate carcinoma LNCaP cells

  2007cites this paper
• Serum Levels of Vascular Endothelial Growth Factor (VEGF) as a Prognostic Factor in Renal Cell Carcinoma

  2007cites this paper
• Renal cell carcinoma: current status and emerging therapies.

  2007cites this paper
• MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses

  2006cites this paper
• Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma

  2006cites this paper
• Renal cell cancer

  2006cites this paper
• Mitochondrial disorders in renal tumors.

  2006cites this paper
• Mismatch repair genes in renal cortical neoplasms.

  2006cites this paper
• Surgical management of low-stage renal cell carcinoma: Technology does not supersede biology.

  2006cites this paper
• Phase I/II study of thalidomide in combination with interleukin‐2 in patients with metastatic renal cell carcinoma

  2006cites this paper
• Expression of Calbindin-D28K in Sporadic Nephroblastomas of the Chicken

  2006cites this paper
• Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo.

  2006cites this paper
• Vascular endothelial growth factor in renal cell carcinoma

  2006cites this paper
• Renal Oncocytoma on 1-11C acetate Positron Emission Tomography: Case Report and Literature Review

  2006cites this paper
• S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.

  2006cites this paper
• Identification of novel target genes by an epigenetic reactivation screen of renal cancer.

  2006cites this paper
• Bellini Duct carcinoma- A Case Report

  2006cites this paper
• Renal Tumors 2006: Lessons Learned and What the Future Holds

  2006cites this paper
• Heat shock proteins in renal cell carcinomas.

  2005cites this paper
• Recently recognized epithelial tumours of the kidney

  2005cites this paper